These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7685119)

  • 1. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.
    Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
    González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
    J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice.
    Miyahira Y; García-Sastre A; Rodriguez D; Rodriguez JR; Murata K; Tsuji M; Palese P; Esteban M; Zavala F; Nussenzweig RS
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3954-9. PubMed ID: 9520474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.
    Sedegah M; Chiang CH; Weiss WR; Mellouk S; Cochran MD; Houghten RA; Beaudoin RL; Smith D; Hoffman SL
    Vaccine; 1992; 10(9):578-84. PubMed ID: 1323900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
    Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
    PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.
    Rodrigues EG; Zavala F; Eichinger D; Wilson JM; Tsuji M
    J Immunol; 1997 Feb; 158(3):1268-74. PubMed ID: 9013969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
    Wang HH; Rogers WO; Kang YH; Sedegah M; Hoffman SL
    Mol Biochem Parasitol; 1995 Feb; 69(2):139-48. PubMed ID: 7770079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
    Connors M; Kulkarni AB; Collins PL; Firestone CY; Holmes KL; Morse HC; Murphy BR
    J Virol; 1992 Feb; 66(2):1277-81. PubMed ID: 1731105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
    Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi.
    Miyahira Y; Kobayashi S; Takeuchi T; Kamiyama T; Nara T; Nakajima-Shimada J; Aoki T
    Int Immunol; 1999 Feb; 11(2):133-41. PubMed ID: 10069411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
    Rodrigues MM; Cordey AS; Arreaza G; Corradin G; Romero P; Maryanski JL; Nussenzweig RS; Zavala F
    Int Immunol; 1991 Jun; 3(6):579-85. PubMed ID: 1716146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.
    Tsuji M; Bergmann CC; Takita-Sonoda Y; Murata K; Rodrigues EG; Nussenzweig RS; Zavala F
    J Virol; 1998 Aug; 72(8):6907-10. PubMed ID: 9658144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
    Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
    Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.
    Rénia L; Marussig MS; Grillot D; Pied S; Corradin G; Miltgen F; Del Giudice G; Mazier D
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7963-7. PubMed ID: 1680235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.
    Sedegah M; Beaudoin RL; Majarian WR; Cochran MD; Chiang CH; Sadoff J; Aggarwal A; Charoenvit Y; Hoffman SL
    Bull World Health Organ; 1990; 68 Suppl(Suppl):109-14. PubMed ID: 2094576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.